Geopolitics Is No Longer a Footnote in Medtech Strategy — It's the Plan

Here is a short roundup of recent medical sales, medical device sales, medtech, pharma, and biotech headlines — useful context for reps, RSDs, and hiring teams watching the market.

Headlines worth watching

• Geopolitics Is No Longer a Footnote in Medtech Strategy — It's the Plan (Medical Device and Diagnostic industry): Geopolitical instability and AI regulation fragmentation are forcing medtech companies to rethink clinical and supply chain strategy from the start.
• AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry (MedTech Dive): In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird's eye view of...
• Reflective Representation in Clinical Research and Data (AdvaMed® - Advanced Medical Technology Association®): Examine the medtech investment landscape, share lessons learned, and discuss strategies that help women's health companies attract funding.
• Solventum Counts On Penetration, Not Market Growth, To Power Growth After HIS Exit (Medtech Insight): Solventum raised 2026 EPS guidance and says the 3M separation is more than 90% complete after its biggest ERP cutover. Exiting HIS would dilute operating...
• IBD Stock Of The Day Bucks Postelection Medtech Malaise (Investor's Business Daily): Quest Diagnostics is Friday's IBD Stock Of The Day. Shares are in a buy zone, shaking off election-tied worries that have hammered healthcare.

Source links

What this means for medical sales careers

Product launches, clearances, and commercial expansion often show up first as hiring demand for territory managers, clinical specialists, and specialty sales roles. Use the headlines above as conversation starters — then verify openings and fit before you apply or post a role.